Equity Brief · Healthcare2026-05-20
FRE.DE·Healthcare

Fresenius SE & Co. KGaA

I · AI-analyse

In het kort

Fresenius runs two main businesses: Fresenius Kabi makes biopharmaceuticals, IV drugs, clinical nutrition products, and medical devices for critically and chronically ill patients, while Fresenius Helios operates hospitals, medical care centers, and outpatient facilities across multiple continents [Yahoo Finance]. The company also develops biosimilar drugs and medical technologies including infusion pumps and apheresis machines [Yahoo Finance].

Fresenius SE & Co. KGaA is a German healthcare company operating hospitals (Fresenius Helios) and producing critical-care pharmaceuticals and medical devices (Fresenius Kabi) across North America, Europe, Asia-Pacific, Latin America, and Africa [Yahoo Finance]. The company employs 177,783 people and generated EUR 22.9 billion in revenue with modest growth of +4.8% year-over-year [Yahoo Finance]. Its subsidiary Fresenius Medical Care recently reported earnings that were stronger than headlines suggested, with EUR 216 million in one-time costs masking underlying profitability [Yahoo Finance].

Fresenius shows moderate financial health with steady cash generation but elevated debt levels that limit flexibility.

In het kort AI analysisBetrouwbaarheid 6/10

Sentinellis-score

4.7/10

Moderate concerns

Marktkapitalisatie

EUR 22.3B

Omzet (12 maanden)

EUR 22.9B

II · Recent nieuws

Wat de koers bewoog

2 stories · ranked by relevance

  • macro2026-05-17

    Just Four Days Till Fresenius Medical Care AG (ETR:FME) Will Be Trading Ex-Dividend

    Simply Wall St

  • macro2026-05-14

    Fresenius Medical Care's (ETR:FME) Solid Earnings Have Been Accounted For Conservatively

    Yahoo Finance

Premium · gratis met elk account

High debt load at 3.4x net debt-to-EBITDA leaves limited room for acquisition financing or weathering revenue shocks, particularly important for a capital-intensive hospital operator [Yahoo Finance]

1 van 4 risico's in dit rapport

Risico's

4

Kansen

5

Waarschuwingssignalen

2

Leiding

6

Nog 16 bevindingen in het volledige rapport — gratis met elk account.

Ontgrendel de volledige analyse van Fresenius SE & Co. KGaA

Maak een gratis account voor het volledige AI-rapport met bronvermelding in de tekst.

  • 4 risico's, 5 kansen en 2 waarschuwingssignalen — elk met zijn bron
  • Meer dan 100 financiële cijfers met grafieken en vergelijkingen
  • Volledige nieuwssamenvattingen met bronlinks
  • Directie en beloning
  • PDF-export voor offline
Ontgrendel alle 11 bevindingen3 gratis rapporten · geen creditcard

III · Vergelijkbare bedrijven

Misschien ook interessant

Same sector · Healthcare or comparable health

Op je volglijst zetten?

Read three companies free. Geen kaart.

Krijg 3 gratis rapporten